Company NPS Pharmaceuticals, Inc.
Equities
US62936P1030
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2015 | NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval | RE |
2015 | NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase | RE |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 108,581,155 | 108,074,845 ( 99.53 %) | 0 | 99.53 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- Stock
- Company NPS Pharmaceuticals, Inc.